Brinker Capital Investments, LLC Castle Biosciences Inc Transaction History

Brinker Capital Investments, LLC

  • $10.5 Billion
  • Q2 2025

A detailed history of Brinker Capital Investments, LLC transactions in Castle Biosciences Inc stock. As of the latest transaction made, Brinker Capital Investments, LLC holds 76,532 shares of CSTL stock, worth $1.85 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
76,532
Previous 76,532 -0.0%
Holding current value
$1.85 Million
Previous $1.56 Million -0.0%
% of portfolio
0.01%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
SELL
$15.8 - $21.98 $29,656 - $41,256
-1,877 Reduced 2.39%
76,532 $1.56 Million
Q1 2025

Jul 31, 2025
BUY
$18.76 - $32.72 $189,344 - $330,242
10,093 Added 14.77%
78,409 $1.57 Million
Q4 2024

Jul 31, 2025
SELL
$26.52 - $34.67 $108,440 - $141,765
-4,089 Reduced 5.65%
68,316 $1.82 Million
Q3 2024

Jul 31, 2025
BUY
$17.4 - $31.47 $179,637 - $324,896
10,324 Added 16.63%
72,405 $2.06 Million
Q2 2024

Jul 31, 2025
SELL
$18.84 - $24.94 $97,139 - $128,590
-5,156 Reduced 7.67%
62,081 $1.35 Million
Q1 2024

Jul 31, 2025
SELL
$18.06 - $25.3 $45,077 - $63,148
-2,496 Reduced 3.58%
67,237 $1.49 Million
Q4 2023

Jul 31, 2025
SELL
$12.19 - $22.43 $52,343 - $96,314
-4,294 Reduced 5.8%
69,733 $1.5 Million
Q3 2023

Jul 31, 2025
SELL
$13.28 - $20.3 $46,785 - $71,516
-3,523 Reduced 4.54%
74,027 $1.25 Million
Q2 2023

Jul 31, 2025
BUY
$11.66 - $26.0 $558,339 - $1.25 Million
47,885 Added 161.42%
77,550 $1.06 Million
Q1 2023

Jul 31, 2025
SELL
$19.47 - $28.49 $61,505 - $89,999
-3,159 Reduced 9.62%
29,665 $673,000
Q4 2022

Feb 06, 2023
SELL
$18.08 - $30.0 $65,738 - $109,080
-3,636 Reduced 9.97%
32,824 $772,000
Q3 2022

Nov 01, 2022
BUY
$22.51 - $34.32 $177,423 - $270,510
7,882 Added 27.58%
36,460 $951,000
Q2 2022

Jul 18, 2022
SELL
$16.0 - $45.99 $106,928 - $307,351
-6,683 Reduced 18.95%
28,578 $627,000
Q1 2022

May 16, 2022
BUY
$33.17 - $46.98 $250,134 - $354,276
7,541 Added 27.2%
35,261 $1.58 Million
Q4 2021

Feb 08, 2022
SELL
$39.06 - $67.58 $876,545 - $1.52 Million
-22,441 Reduced 44.74%
27,720 $1.19 Million
Q2 2021

Aug 03, 2021
BUY
$50.07 - $76.78 $2.51 Million - $3.85 Million
50,161 New
50,161 $3.68 Million

Others Institutions Holding CSTL

# of Institutions
170
Shares Held
27.9M
Call Options Held
0
Put Options Held
0
View Full List

About CASTLE BIOSCIENCES INC

CSTL Quotes by TradingView
  • Ticker CSTL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 26,297,000
  • Market Cap $637M
  • Description
  • Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...
More about CSTL
Track This Portfolio

Track Brinker Capital Investments, LLC Portfolio

Follow Brinker Capital Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brinker Capital Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brinker Capital Investments, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email